JP2014501513A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501513A5
JP2014501513A5 JP2013541012A JP2013541012A JP2014501513A5 JP 2014501513 A5 JP2014501513 A5 JP 2014501513A5 JP 2013541012 A JP2013541012 A JP 2013541012A JP 2013541012 A JP2013541012 A JP 2013541012A JP 2014501513 A5 JP2014501513 A5 JP 2014501513A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
variable region
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013541012A
Other languages
English (en)
Japanese (ja)
Other versions
JP6033229B2 (ja
JP2014501513A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/061785 external-priority patent/WO2012071381A1/en
Publication of JP2014501513A publication Critical patent/JP2014501513A/ja
Publication of JP2014501513A5 publication Critical patent/JP2014501513A5/ja
Application granted granted Critical
Publication of JP6033229B2 publication Critical patent/JP6033229B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013541012A 2010-11-24 2011-11-22 Notumペクチンアセチルエステラーゼと結合する抗体 Expired - Fee Related JP6033229B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41692710P 2010-11-24 2010-11-24
US61/416,927 2010-11-24
PCT/US2011/061785 WO2012071381A1 (en) 2010-11-24 2011-11-22 Antibodies to notum pectinacetylesterase

Publications (3)

Publication Number Publication Date
JP2014501513A JP2014501513A (ja) 2014-01-23
JP2014501513A5 true JP2014501513A5 (https=) 2014-12-25
JP6033229B2 JP6033229B2 (ja) 2016-11-30

Family

ID=46146184

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013541012A Expired - Fee Related JP6033229B2 (ja) 2010-11-24 2011-11-22 Notumペクチンアセチルエステラーゼと結合する抗体

Country Status (21)

Country Link
US (3) US20130302346A1 (https=)
EP (1) EP2643019B1 (https=)
JP (1) JP6033229B2 (https=)
KR (2) KR20140026334A (https=)
CN (1) CN103298490B (https=)
AU (1) AU2011332007C1 (https=)
BR (1) BR112013012858B1 (https=)
CA (1) CA2817415C (https=)
CO (1) CO6721048A2 (https=)
DK (1) DK2643019T3 (https=)
ES (1) ES2718849T3 (https=)
HU (1) HUE043576T2 (https=)
IL (1) IL225876A0 (https=)
MX (2) MX357166B (https=)
NZ (1) NZ609501A (https=)
PL (1) PL2643019T3 (https=)
PT (1) PT2643019T (https=)
RU (1) RU2013123793A (https=)
SG (1) SG189982A1 (https=)
WO (1) WO2012071381A1 (https=)
ZA (1) ZA201302983B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809369A1 (en) * 2010-08-27 2012-03-01 Stem Centrx, Inc. Notum protein modulators and methods of use
JP6033229B2 (ja) 2010-11-24 2016-11-30 レクシコン ファーマシューティカルズ インコーポレイテッド Notumペクチンアセチルエステラーゼと結合する抗体
DK3252076T3 (da) 2011-01-14 2019-12-02 Univ California Diagnostisk anvendelse af antistoffer mod ror-1-protein
US8802365B2 (en) * 2011-03-22 2014-08-12 Whitehead Institute For Biomedical Research Methods for identifying candidate modulators of NOTUM activity
IN2015DN00140A (https=) * 2012-08-31 2015-06-12 Argen X Bv
US10227408B2 (en) 2015-02-19 2019-03-12 Compugen Ltd. Anti-PVRIG antibodies and methods of use
CN110088132B (zh) 2016-08-17 2020-10-27 康姆普根有限公司 抗tigit抗体,抗pvrig抗体及其组合
WO2020150282A1 (en) * 2019-01-18 2020-07-23 Askgene Pharma Inc. Pd-l1 specific monoclonal antibodies for disease treatment and diagnosis
CN110317271B (zh) * 2019-07-02 2021-04-30 武汉云克隆科技股份有限公司 一种pinp重组抗体的重/轻链可变区及编码基因和重组抗体
AU2021400733A1 (en) * 2020-12-16 2023-07-13 Memorial Sloan Kettering Cancer Center Cd40 binding molecules and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
DE3374837D1 (en) 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
EP0143949B1 (en) 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmaceutical composition containing urokinase
EP0154316B1 (en) 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemically modified lymphokine and production thereof
EP0401384B1 (en) 1988-12-22 1996-03-13 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
US6075181A (en) 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP1690934A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
DK0575545T3 (da) 1991-03-15 2003-09-15 Amgen Inc Pegylering af polypeptider
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
TW313568B (https=) 1994-12-20 1997-08-21 Hoffmann La Roche
US6127977A (en) 1996-11-08 2000-10-03 Cohen; Nathan Microstrip patch antenna with fractal structure
EP1500329B1 (en) 1996-12-03 2012-03-21 Amgen Fremont Inc. Human antibodies that specifically bind human TNF alpha
US6080576A (en) 1998-03-27 2000-06-27 Lexicon Genetics Incorporated Vectors for gene trapping and gene activation
GB0201808D0 (en) * 2002-01-25 2002-03-13 European Molecular Biology Lab Embl Protein
US20040063924A1 (en) * 2002-01-28 2004-04-01 Y Tom Tang Secreted proteins
EP1652923B1 (en) * 2003-08-08 2011-10-12 Perseus Proteomics Inc. Gene overexpressed in cancer
CA2809369A1 (en) * 2010-08-27 2012-03-01 Stem Centrx, Inc. Notum protein modulators and methods of use
JP6033229B2 (ja) 2010-11-24 2016-11-30 レクシコン ファーマシューティカルズ インコーポレイテッド Notumペクチンアセチルエステラーゼと結合する抗体

Similar Documents

Publication Publication Date Title
JP2014501513A5 (https=)
RU2495050C2 (ru) Связующий элемент для рецептора gm-csf
JP2010526028A5 (https=)
CA2758252C (en) Dkk-1 antibodies
JP2017536354A5 (https=)
JP2018521691A5 (https=)
JP2021521843A5 (https=)
JP2019522961A5 (https=)
JP2013538553A5 (https=)
JP2006512899A5 (https=)
JP2014500009A5 (https=)
JP2015503909A5 (https=)
JP2014524748A5 (https=)
JP6875275B2 (ja) L1cam(cd17)と結合する抗体などの結合分子
JP2008542278A5 (https=)
JP2019514844A5 (https=)
JP2018521638A5 (https=)
JP2014534806A5 (https=)
JP2018502060A5 (https=)
JP2012513214A5 (https=)
HRP20140618T1 (hr) Protutijela protiv beta-amiloidnog peptida
HRP20140108T1 (hr) Protutijela protiv sklerostina
JP2015529641A5 (https=)
JP2012501670A5 (https=)
RU2013123793A (ru) Антитела, связывающиеся с notum пектинацетилэстеразой